{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:25:49Z","timestamp":1791127549114,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejpb.2006.12.002","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T07:10:57Z","timestamp":1166080257000},"page":"466-474","source":"Crossref","is-referenced-by-count":41,"title":["Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy"],"prefix":"10.1016","volume":"66","author":[{"given":"F.","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"McGoverin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Strachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2006.12.002_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1023\/A:1016241927429","article-title":"Pharmaceutical solids: a strategic approach to regulatory considerations","volume":"12","author":"Byrn","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.12.002_bib2","unstructured":"Guidance for Industry. PAT \u2013 a framework for innovative pharmaceutical manufacturing and quality assurance, U.S. Food and Drug Administration (FDA), Rockville, MD, USA, 2004, 21."},{"key":"10.1016\/j.ejpb.2006.12.002_bib3","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1023\/A:1015872626887","article-title":"The bioinequivalence of carbamazepine tablets with a history of clinic failures","volume":"9","author":"Meyer","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.12.002_bib4","first-page":"2245","article-title":"Structure of carbamazepine: 5H-Dibenz[b,f]azepine-5-carboxamide","volume":"B37","author":"Himes","year":"1981","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejpb.2006.12.002_bib5","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","article-title":"Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I","volume":"92","author":"Grzesiak","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.12.002_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(89)90357-8","article-title":"Effect of type and extent of crystalline order on chemical and physical stability of carbamazepine","volume":"53","author":"Krahn","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.12.002_bib7","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/crat.2170211118","article-title":"The order-disorder structure of carbamazepine dihydrate: 5H-dibenz[b,f]azepine-5-carboxamide dihydrate, C15H12N2O","volume":"21","author":"Reck","year":"1986","journal-title":"Cryst. Res. Technol."},{"key":"10.1016\/j.ejpb.2006.12.002_bib8","series-title":"Physical characterization of pharmaceutical solids","first-page":"1","year":"1995"},{"key":"10.1016\/j.ejpb.2006.12.002_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1023\/A:1015970218980","article-title":"Determination of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O. 2H2O) in a mixture by powder X-ray diffractometry","volume":"6","author":"Suryanarayanan","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.12.002_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/10837459809028643","article-title":"Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate","volume":"3","author":"Han","year":"1998","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2006.12.002_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jps.2600800519","article-title":"Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions","volume":"80","author":"Yong","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.12.002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/ac0006674","article-title":"Full phase analysis of Portland Clinker by penetrating synchrotron powder diffraction","volume":"73","author":"De La Torre","year":"2001","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2006.12.002_bib13","series-title":"Certificate of Analysis; Standard Reference Material 1878a","author":"Kaiser","year":"2005"},{"key":"10.1016\/j.ejpb.2006.12.002_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0885715600015608","article-title":"Determination of the relative amounts of a-carbamazepine and b-carbamazepine in a mixture by powder X-ray diffractometry","volume":"5","author":"Suryanarayanan","year":"1990","journal-title":"Powder Diffr."},{"key":"10.1016\/j.ejpb.2006.12.002_bib15","series-title":"Physical Characterization of Pharmaceutical Solids","first-page":"187","article-title":"X-ray powder diffractometry","author":"Suryanarayanan","year":"1995"},{"key":"10.1016\/j.ejpb.2006.12.002_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpba.2005.07.030","article-title":"Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy","volume":"40","author":"Tian","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2006.12.002_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jrs.1140","article-title":"Quantitative analysis of polymorphic mixtures of carbamazepine by Raman spectroscopy and principal components analysis","volume":"35","author":"Strachan","year":"2004","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.ejpb.2006.12.002_bib18","series-title":"Handbook of Raman Spectroscopy: From the Research Laboratory to the Process Line","first-page":"575","article-title":"Some pharmaceutical application of Raman spectroscopy","author":"Williams","year":"2001"},{"key":"10.1016\/j.ejpb.2006.12.002_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jps.20241","article-title":"In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy","volume":"94","author":"Wikstr\u00f6m","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.12.002_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jps.10267","article-title":"Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes","volume":"92","author":"Anquetil","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.12.002_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0731-7085(02)00059-6","article-title":"Quantitative analysis of mannitol polymorphs, FT-Raman spectroscopy","volume":"28","author":"Campbell Roberts","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2006.12.002_bib22","first-page":"30","article-title":"Raman spectroscopy for pharma. Part II: Raman as a PAT tool","volume":"17","author":"Webster","year":"2005","journal-title":"Pharma. Technol. Eur."},{"key":"10.1016\/j.ejpb.2006.12.002_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/op030031p","article-title":"In situ monitoring of polymorphic transitions","volume":"7","author":"Sullivan","year":"2003","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejpb.2006.12.002_bib24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1366\/000370202321115779","article-title":"Effect of powder properties on the intensity of Raman scattering by crystalline solids","volume":"56","author":"Wang","year":"2002","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ejpb.2006.12.002_bib25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0584-8539(91)80208-Z","article-title":"A comparison of Fourier transform infrared and near-infrared Fourier transform Raman spectroscopy for quantitative measurements: an application in polymorphism","volume":"47A","author":"Deeley","year":"1991","journal-title":"Spectrochim. Acta, Part A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejpb.2006.12.002_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0731-7085(96)01906-1","article-title":"Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound","volume":"15","author":"Langkilde","year":"1997","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2006.12.002_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1011979221685","article-title":"The quantitative analysis of crystallinity using FT-Raman spectroscopy","volume":"15","author":"Taylor","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.12.002_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1366\/0003702054411553","article-title":"Comparison of sampling techniques for in-line monitoring using Raman spectroscopy","volume":"59","author":"Wikstr\u00f6m","year":"2005","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ejpb.2006.12.002_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpba.2005.04.029","article-title":"Characterization of different laser irradiation methods for quantitative Raman tablet assessment","volume":"39","author":"Johansson","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2006.12.002_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(01)00101-6","article-title":"Characterization of the solid state: spectroscopic techniques","volume":"48","author":"Bugay","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2006.12.002_bib31","unstructured":"F. Tian, N. Sandler, J. Aaltonen, C. Lang, D.J. Saville, K.C. Gordon, C.J. Strachan, J. Rantanen, T. Rades, Influence of polymorphic form, morphology and excipient interactions on the dissolution of carbamazepine compacts, J. Pharm. Sci. in press."},{"key":"10.1016\/j.ejpb.2006.12.002_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1088\/0957-0233\/16\/1\/040","article-title":"Multivariate and univariate analysis of infrared imaging data for high-throughput studies of NH3 decomposition and NOx storage and reduction catalysts","volume":"16","author":"Hendershot","year":"2005","journal-title":"Meas. Sci. Technol."},{"key":"10.1016\/j.ejpb.2006.12.002_bib33","series-title":"The Merck Index","author":"Windholz","year":"1983"},{"key":"10.1016\/j.ejpb.2006.12.002_bib34","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jps.20690","article-title":"Simultaneous quantification of carbamazepine crystal forms in ternary mixtures (I, III, and IV) by diffuse reflectance FTIR spectroscopy (DRIFTS) and multivariate calibration","volume":"95","author":"Kipouros","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.12.002_bib35","unstructured":"International Conference on Harmonization, ICH Harmonised Tripartite Guideline-Validation of analytical procedures: Method. Fed Regist, 62 (1997), 27463."},{"key":"10.1016\/j.ejpb.2006.12.002_bib36","first-page":"492","article-title":"The X-ray identification and crystal structures of clay minerals","author":"Brindley","year":"1961"},{"key":"10.1016\/j.ejpb.2006.12.002_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1107\/S0021889801012237","article-title":"Micro X-ray diffraction on capillary powder samples: a novel and effective technique for overcoming preferred orientation","volume":"34","author":"Bergese","year":"2001","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejpb.2006.12.002_bib38","first-page":"495","article-title":"Industrial Application of X-ray Diffraction","author":"Murthy","year":"2001"},{"key":"10.1016\/j.ejpb.2006.12.002_bib39","first-page":"68","article-title":"Minimization of microabsorption effects in complex mixtures","volume":"46","author":"Pederson","year":"2003","journal-title":"International Center for Diffraction Data, Adv. X-ray Anal."},{"key":"10.1016\/j.ejpb.2006.12.002_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/cg0503402","article-title":"In situ monitoring and modeling of the solvent-mediated polymorphic transformation of l-glutamic acid","volume":"6","author":"Sch\u00f6ll","year":"2006","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2006.12.002_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jrs.1160","article-title":"Development of sampling methods for Raman analysis of solid dosage forms of therapeutic and illicit drugs","volume":"35","author":"Bell","year":"2004","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.ejpb.2006.12.002_bib42","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/cg0600593","article-title":"Solvent-mediated phase transformation kinetics of an anhydrate\/hydrate system","volume":"6","author":"Qu","year":"2006","journal-title":"Cryst. Growth Des."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106003523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106003523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:52:14Z","timestamp":1547139134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641106003523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0939641106003523"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2006.12.002","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}